Development of Assays for high Throughput Drug Screening (R01)

The summary for the Development of Assays for high Throughput Drug Screening (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Development of Assays for high Throughput Drug Screening (R01): -Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to encourage the use of high throughput small molecule screening for use in both research and drug discovery programs by funding the development of innovative assays that may be adapted for automated screening. The assays would aim to identify new tools for basic research and promising new avenues for therapeutics development, especially in areas related to the missions of NIDDK, NCI and NIAID. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.